Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Current Deferred Revenue (2016 - 2017)

Historic Current Deferred Revenue for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2017 value amounting to $20000.0.

  • Armata Pharmaceuticals' Current Deferred Revenue rose 1111.11% to $20000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $20000.0, marking a year-over-year increase of 1111.11%. This contributed to the annual value of $245000.0 for FY2015, which is 40.98% up from last year.
  • According to the latest figures from Q3 2017, Armata Pharmaceuticals' Current Deferred Revenue is $20000.0, which was up 1111.11% from $58000.0 recorded in Q2 2017.
  • Over the past 5 years, Armata Pharmaceuticals' Current Deferred Revenue peaked at $350000.0 during Q2 2015, and registered a low of $18000.0 during Q3 2016.
  • For the 5-year period, Armata Pharmaceuticals' Current Deferred Revenue averaged around $171600.0, with its median value being $142000.0 (2015).
  • As far as peak fluctuations go, Armata Pharmaceuticals' Current Deferred Revenue tumbled by 9271.26% in 2016, and later soared by 3488.37% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' Current Deferred Revenue (Quarter) stood at $244000.0 in 2013, then changed by 0.0% to $244000.0 in 2014, then grew by 0.41% to $245000.0 in 2015, then plummeted by 92.65% to $18000.0 in 2016, then increased by 11.11% to $20000.0 in 2017.
  • Its Current Deferred Revenue was $20000.0 in Q3 2017, compared to $58000.0 in Q2 2017 and $86000.0 in Q1 2017.